Secukinumab (anti-IL-17A) [1229022-83-6]
A2025
Product group Chemicals
Overview
- SupplierSelleck Chemicals
- Product NameSecukinumab (anti-IL-17A) [1229022-83-6]
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionSecukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1kappa monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
- UNSPSC12352200